Plesha Scott M. 4
4 · Pelthos Therapeutics Inc. · Filed Jul 23, 2025
Insider Transaction Report
Form 4
Plesha Scott M.
DirectorCEO and President
Transactions
- Award
Restricted Stock Units
2025-07-02+83,678→ 83,678 totalExercise: $13.50From: 2026-07-02Exp: 2035-07-02→ Common Stock (83,678 underlying) - Award
Stock Option
2025-07-02+255,000→ 255,000 totalExercise: $13.50From: 2026-07-02Exp: 2035-07-02→ Common Stock (255,000 underlying)
Footnotes (2)
- [F1]On July 2, 2025, the Reporting Person was granted restricted stock units to purchase 83,678 shares of common stock at an exercise price of $13.50 per share, with the initial one third (1/3) of such shares vesting on July 2, 2026, and in equal installments on a quarterly basis thereafter over a period of two (2) years.
- [F2]On July 2, 2025, the Reporting Person was granted stock options to purchase 255,000 shares of common stock at an exercise price of $13.50 per share, with the initial one third (1/3) of such shares vesting on July 2, 2026, and in equal installments on a quarterly basis thereafter over a period of two (2) years.